首页> 外国专利> METHOD FOR THE TREATMENT OF EXPERIMENTAL myocardial infarction in rats

METHOD FOR THE TREATMENT OF EXPERIMENTAL myocardial infarction in rats

机译:治疗大鼠实验性心肌梗死的方法

摘要

1. A method of treatment of experimental myocardial infarction, based on modeling of myocardial infarction with subsequent medical intervention, characterized in that the intravenous administration is performed L-17 compound from the class of 1,3,4-thiadiazines dosage of 40 mg / kg after creation of myocardial infarction model, with followed by histological examination of myocardial tissue. ! 2. A method according to claim 1, characterized in that the compounds L-17, acting on the nature of the reaction ostrovospalitelnoy (reduces delivery of neutrophils that produce inflammation stimulating factors) corrects during the acute phase of systemic inflammatory response syndrome, which reduces the expression of leukocyte reaction, stimulates the migration of cells immunocompetent lymphocytes, plasma cells, mast cells, macrophages in the necrotic foci, accelerates the formation of granulation tissue with proliferation of fibroblasts cells nical number and causes substitution of necrotic area of ​​scar tissue provided active fibroblasts and fibrous structures.
机译:1.一种治疗心肌梗塞的方法,其基于对心肌梗塞的建模并随后进行医学干预,其特征在于静脉内给药是从1,3,4-噻二嗪类的L-17化合物中进行的,剂量为40 mg /千克后,建立心肌梗死模型,随后对心肌组织进行组织学检查。 ! 2.根据权利要求1所述的方法,其特征在于,作用于ostrovospalitelnoy反应(减少产生炎症刺激因子的嗜中性粒细胞的递送)的性质的化合物L-17在系统性炎症反应综合征的急性期纠正,其降低白细胞反应的表达,刺激坏死灶中具有免疫功能的淋巴细胞,浆细胞,肥大细胞,巨噬细胞的迁移,促进成肉组织的形成并增加成纤维细胞的数目,并导致瘢痕组织坏死区域的置换提供了活跃的成纤维细胞和纤维结构。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号